Ticker

No recent analyst price targets found for LABD.

Latest News for LABD

Navigate Biotech's Crosscurrents With Direxion's LABU And LABD ETFs

Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push toward addressing the human condition — which is often found to be shockingly frail.

Benzinga • Dec 18, 2025

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for LABD.

No Senate trades found for LABD.

No House trades found for LABD.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top